GRACE ROBERTSON: Open Payments
NPI 1861155426 · NORTH CHELMSFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 48 payments from 7 companies in 2025. Trend: 2023 $1,155 · 2024 $1,403 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $333 |
| ABBVIE INC. | 11 | $228 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $166 |
| Lundbeck LLC | 8 | $142 |
| E.R. Squibb & Sons, L.L.C. | 4 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $79 |
| Alkermes, Inc. | 3 | $63 |
Products named: REXULTI, VRAYLAR, CAPLYTA, COBENFY, TRINTELLIX, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across MA — which companies pay providers there.
